Stock Alerts! From Pennytobuck.com - Proteonomix, Inc., Prot.ob, Kv-a, Ktos, Ksw

PROT, Proteonomix, Inc., PROT.OB

PROT, Proteonomix, Inc., PROT.OB

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives.

PROT reported further developments with its Joint Venture Company, XGEN Medical LLC (XGen) towards implementing operations in the United Arab Emirates (U.A.E.).

PROT is the majority shareholder in XGen with the balance held by an anonymous investor group. (51% by PROT and 49% by the Investor Group)

Proteonomix's personnel were on the ground in the U.A.E. over the past weeks to work together with the Investor Group through the start up phase. To date, XGen has established an office in the Monarch Office Tower on the prestigious Sheikh Zayed Road, and a residence for visiting Proteonomix personnel on Jumeira 2.

During initial meetings, it was mutually decided to open a local subsidiary corporation in the Dubai free zone. This wholly owned subsidiary will be the vehicle to conduct business in the GCC countries.

XGen has filed the corporate papers and has established banking relations with a local bank both for receipt of the initial investment of $5 million and towards further financing expanded services in the region.

The Ramadan holiday has slowed progress slightly on these corporate formalities, but full operation of the subsidiary and bank accounts are expected to complete within 30 days.

Proteonomix plans to issue updates regarding the implementation of the Joint Venture Agreement in the near future.

LAST TRADE: 2.00

VOLUME: 2,716

To learn more about PROT visit: www.proteonomix.com

********************

K-V Pharmaceutical Company, (NYSE: KV-A, KV-B), announced recently that it has entered into an agreement with U.S. Healthcare I, L.L.C. and U.S. Healthcare II, L.L.C. for a $20 million loan secured by assets of the Company. K-V will utilize the proceeds of the loan for working capital and general operating purposes.

The Company, upon the request of U.S. Healthcare I, L.L.C. and U.S. Healthcare II, L.L.C., has entered into a period of exclusivity to negotiate an expanded, longer-term financial arrangement that will align with the Company's future strategic plans.

Under the terms of the loan agreement, which expires January 31, 2011, the Company will pay interest at an annual rate of 16.5%, of which 5% is Payment-in-Kind (PIK). The exclusivity period expires September 28, 2010.

Greg Divis, Interim President and Chief Executive Officer of K-V stated, "The entire Company, along with the Board of Directors have worked hard to secure this agreement which comes shortly after our receiving approval from the U.S. Food and Drug Administration ("FDA") to return our first product to the market. This financing is another important step in returning the Company to normalized operations."

K-V intends to raise additional capital beyond this $20 million loan to provide for ongoing operations beyond the fourth quarter of calendar 2010.

About K-V Pharmaceutical Company

K-V Pharmaceutical Company is a fully-integrated specialty pharmaceutical company that develops, manufactures, markets and acquires technology-distinguished branded prescription products. The Company markets its technology-distinguished products through Ther-Rx Corporation, its branded drug subsidiary.

For further information about K-V Pharmaceutical Company, please visit the Company's website at www.kvpharmaceutical.com

********************

Kratos Defense & Security Solutions Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its Federal Civilian Services team has been awarded a new, three-year task order supporting the Department of Education's (ED) Office of Vocational and Adult Education (OVAE). This task order will aid low-skilled adult workers to transition to employment through career pathways, planned and sequenced courses of study leading to an industry recognized certificate, credential or postsecondary education. Designing Instruction for Career Pathways will provide high quality technical assistance (TA) to state and local adult education providers, enabling them to design and implement career pathways programming to low-skilled adults.

The contract is expected to be performed over a three-year period, with a total contract value of approximately $3.6 million.

The project will efficiently leverage previous ED investments to support the transition of low-skilled adults into postsecondary education and employment. Designing Instruction for Career Pathways also supports the broad goals of The American Recovery and Reinvestment Act of 2009 as well as the President's goal for all workers to complete at least a year of postsecondary education or advanced training.

Kratos has a successful 14-year relationship with the Department of Education, having served agencies including the Office of Elementary and Secondary Education, the Office of Special Education and Rehabilitative Services, the Office of Vocational and Adult Education, and the Office of Postsecondary Education. Kratos has supported numerous initiatives including the National School-to-Work Office, the Smaller Learning Communities Program, America's Career Resource Network, Student Achievement in Reading (STAR) and Policy to Performance, the Adult Basic Education to Postsecondary Education initiative.

Kratos Defense & Security Solutions, Inc. provides mission critical products, services and solutions for United States National Security. Principal products, services and solution offerings relate to and support C5ISR, weapon systems sustainment, military weapon range operations and technical services, network engineering services, information assurance and cyber security solutions, security and surveillance systems, and critical infrastructure security system design and integration. The Company is headquartered in San Diego, California, with resources located throughout the U.S. and at key strategic military locations.

News and information are available at www.KratosDefense.com

*****************************

KSW, Inc. (NASDAQ GM:KSW) reported preliminary financial results for the second quarter of 2010.

Net income for the second quarter of 2010 was $721,000, or $.11 per share (basic and diluted), compared to second quarter of 2009 net income of $123,000, or $.02 per share (basic and diluted). Net income for the first six months of 2010 was $808,000, or $0.13 (basic and diluted), as compared to $410,000, or $0.07 per share (basic and diluted), for the first six months of 2009.

Revenues in the second quarter of 2010 were $24,439,000, as compared to $16,621,000 in 2009. Revenues for the first six months of 2010 were $37,899,000, as compared to $36,327,000 for the first six months of 2009.

The Companys backlog as of June 30, 2010 was approximately $95,000,000.

KSW, Inc., through its totally-owned mechanical subsidiary KSW Mechanical Services, Inc., furnishes and installs heating, ventilating and air conditioning (HVAC) systems and process piping systems for institutional, industrial, commercial, high-rise residential and public works projects. KSW Mechanical Services, Inc. also acts as trade manager on larger construction projects, such as the Mount Sinai Center for Science and Medicine.

******************************************************************

For FREE Daily Stock Alerts & Updates Sign-up At: http://pennytobuck.com/signup

******************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)

by: Bill Pennyman

POST COMMENT

Cloth Nappies And How To Wash Them The capital and the largest city of Mali Pros And Cons Of Freehold And Leasehold Property Expenses, Savings and Donations Executing A Smooth Move And Unpacking Effectively Sixaxis And Dualshock 3 Controllers For Playstation 3 Rose Hips Oil Benefits For Keeping Skin Young And Wrinkle-free The Differences Between Pat Testers And Volt Meters Titanium Facts And Uses What Exactly Is Psoriasis And Exactly How Is It Caused? Shark Liver Oil: Uses And Benefits How And Why To Throat Sing With Perfect Harmony Fabric Padded Hangers And Their Use In The Closet